X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs TORRENT PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD TORRENT PHARMA STRIDES SHASUN LTD/
TORRENT PHARMA
 
P/E (TTM) x 15.2 29.7 51.0% View Chart
P/BV x 1.8 5.6 31.1% View Chart
Dividend Yield % 0.6 1.0 58.4%  

Financials

 STRIDES SHASUN LTD   TORRENT PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
TORRENT PHARMA
Mar-17
STRIDES SHASUN LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2751,768 72.1%   
Low Rs9181,186 77.4%   
Sales per share (Unadj.) Rs389.6346.1 112.6%  
Earnings per share (Unadj.) Rs28.055.2 50.7%  
Cash flow per share (Unadj.) Rs48.973.3 66.7%  
Dividends per share (Unadj.) Rs4.5014.00 32.1%  
Dividend yield (eoy) %0.40.9 43.3%  
Book value per share (Unadj.) Rs303.1257.1 117.9%  
Shares outstanding (eoy) m89.42169.22 52.8%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.84.3 66.0%   
Avg P/E ratio x39.226.8 146.5%  
P/CF ratio (eoy) x22.420.1 111.3%  
Price / Book Value ratio x3.65.7 63.0%  
Dividend payout %16.125.4 63.4%   
Avg Mkt Cap Rs m98,036249,887 39.2%   
No. of employees `0005.811.8 49.2%   
Total wages/salary Rs m5,8819,934 59.2%   
Avg. sales/employee Rs Th6,005.94,971.5 120.8%   
Avg. wages/employee Rs Th1,014.0843.2 120.3%   
Avg. net profit/employee Rs Th431.2792.4 54.4%   
INCOME DATA
Net Sales Rs m34,83458,569 59.5%  
Other income Rs m1,6862,233 75.5%   
Total revenues Rs m36,52060,802 60.1%   
Gross profit Rs m6,42813,773 46.7%  
Depreciation Rs m1,8723,069 61.0%   
Interest Rs m2,2692,056 110.4%   
Profit before tax Rs m3,97310,881 36.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4701,545 30.4%   
Profit after tax Rs m2,5019,336 26.8%  
Gross profit margin %18.523.5 78.5%  
Effective tax rate %11.814.2 83.3%   
Net profit margin %7.215.9 45.0%  
BALANCE SHEET DATA
Current assets Rs m38,16553,841 70.9%   
Current liabilities Rs m30,40231,612 96.2%   
Net working cap to sales %22.338.0 58.7%  
Current ratio x1.31.7 73.7%  
Inventory Days Days7797 79.6%  
Debtors Days Days10484 124.7%  
Net fixed assets Rs m37,63942,079 89.4%   
Share capital Rs m894846 105.7%   
"Free" reserves Rs m26,21042,655 61.4%   
Net worth Rs m27,10543,501 62.3%   
Long term debt Rs m16,37722,408 73.1%   
Total assets Rs m81,168101,250 80.2%  
Interest coverage x2.86.3 43.7%   
Debt to equity ratio x0.60.5 117.3%  
Sales to assets ratio x0.40.6 74.2%   
Return on assets %5.911.3 52.2%  
Return on equity %9.221.5 43.0%  
Return on capital %12.119.6 61.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,46520,066 67.1%   
Fx outflow Rs m4,0765,304 76.8%   
Net fx Rs m9,38914,762 63.6%   
CASH FLOW
From Operations Rs m2,88110,127 28.5%  
From Investments Rs m-7,051-7,869 89.6%  
From Financial Activity Rs m3,382-1,918 -176.3%  
Net Cashflow Rs m-788212 -372.4%  

Share Holding

Indian Promoters % 27.7 71.5 38.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 7.0 538.5%  
FIIs % 8.6 12.6 68.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 8.8 294.3%  
Shareholders   56,241 26,511 212.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   DR. REDDYS LAB  IPCA LABS  NATCO PHARMA  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Positive Note; Apollo Micro Systems IPO Lists at 74% Premium(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 22, 2018 02:03 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS